Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1 (original) (raw)

Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study

Chih-cheng Chen

American Journal of Gastroenterology, 2010

View PDFchevron_right

Statins and primary liver cancer

Giovanni Corrao

European Journal of Cancer Prevention, 2013

View PDFchevron_right

Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis

Siddharth Singh

Gastroenterology, 2013

View PDFchevron_right

Statin use and risk of hepatocellular carcinoma

Hsueh-chou Lai

European Journal of Epidemiology, 2013

View PDFchevron_right

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level

Teemu Murtola

Cancers

View PDFchevron_right

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies

Mohaimenul Islam

Cancers

View PDFchevron_right

Statins and Risk of Cancer

Claudio Marelli

Journal of the American College of Cardiology, 2011

View PDFchevron_right

Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits

P. Massucco

Nutrition, Metabolism and Cardiovascular Diseases, 2004

View PDFchevron_right

Incidence of cancer and statin usage���Record linkage study

Jari Tiihonen

International Journal of Cancer, 2010

View PDFchevron_right

Statins and Cancer Prevention—Association Does Not Mean Causation

Sanjay Das

Cancer Prevention Research

View PDFchevron_right

Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease

Seth Martin, Raul Santos

Archives of Medical Research, 2014

View PDFchevron_right

Statin use and nonalcoholic steatohepatitis in at risk individuals

R. Pipitone

Journal of hepatology, 2015

View PDFchevron_right

Statins and Liver Toxicity: A Meta-Analysis

Andrew Peterson

Pharmacotherapy, 2004

View PDFchevron_right

Statin Use and Reduced Cancer-Related Mortality A BS T R AC T BACKGROUND

dida dlo

View PDFchevron_right

Statins Are Safe for the Treatment of Hypercholesterolemia in Patients With Chronic Liver Disease

william sanchez

Gastroenterology, 2008

View PDFchevron_right

Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink

Sam Mbulaiteye

Gut, 2018

View PDFchevron_right

Safety of Statin Therapy in Patients with Preexisting Liver Disease

Dawn Fuke

Pharmacotherapy, 2008

View PDFchevron_right

The statin-low cholesterol-cancer conundrum

Paul Rosch

QJM, 2012

View PDFchevron_right

Response: Re: The Association Between Statins and Cancer Incidence in a Veterans Population

Mary Brophy, Robert Lew

JNCI Journal of the National Cancer Institute, 2008

View PDFchevron_right

The Association Between Statins and Cancer Incidence in a Veterans Population

Richard Scranton

Journal of The National Cancer Institute, 2008

View PDFchevron_right

Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based Study

Avi Porath

Preventing Chronic Disease, 2012

View PDFchevron_right

Statins in liver disease: A molehill, an iceberg, or neither?

Curtis Argo, Amedeo Lonardo

Hepatology, 2008

View PDFchevron_right

Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort

Michael Thun

Cancer Research, 2011

View PDFchevron_right

Do statins cause cancer? A meta-analysis of large randomized clinical trials

Jacques Lelorier

The American Journal of Medicine, 2001

View PDFchevron_right

Statins and Risk of Cholangiocarcinoma: A Systematic Review and Meta-analysis

Elizabeth Aby

Journal of Gastrointestinal and Liver Diseases

View PDFchevron_right

Statins do not protect against cancer: quite the opposite

Uffe Ravnskov

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015

View PDFchevron_right

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

Vasilios Athyros

The Lancet, 2010

View PDFchevron_right

Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma

Samuel Antwi

Hepatology, 2020

View PDFchevron_right

Real-world Evidence for Preventive Effects of Statins on Cancer Incidence: A Trans-Atlantic Analysis

Benedikt Kortüm

2021

View PDFchevron_right

Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions

Malek Kreidieh

Gastroenterology Research, 2022

View PDFchevron_right

Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly

Soko Setoguchi Iwata

Circulation, 2006

View PDFchevron_right

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

Michael E Murray

Gastroenterology, 2004

View PDFchevron_right

Current views and prospects relating to the use of statins in patients with chronic liver disease and cirrhosis

Innovative Publication

Indian Journal of Pharmacy and Pharmacology, 2023

View PDFchevron_right

Evidence-Based Prediction of Statin Use with Lipid-Panel Data from the National Health and Nutrition Examination Survey

Jeff Guo

2012

View PDFchevron_right

Statins and the liver

Samira Bahrainy

Ceylon Medical Journal, 2010

View PDFchevron_right